We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+8.36%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.58B
AUM Growth
+$568M
Cap. Flow
+$189M
Cap. Flow %
3.39%
Top 10 Hldgs %
17.58%
Holding
1,590
New
158
Increased
732
Reduced
501
Closed
88

Sector Composition

Rank Sector Weight
1 Technology 17.89%
2 Financials 10.71%
3 Healthcare 10.59%
4 Consumer Discretionary 9.99%
5 Industrials 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BILL icon
1376
BILL Holdings
BILL
$4.52B
$224K ﹤0.01%
1,224
-352
-22% -$55.2K
VDE icon
1377
Vanguard Energy ETF
VDE
$9.97B
$223K ﹤0.01%
+2,937
New +$213K
WRB icon
1378
W.R. Berkley
WRB
$27.2B
$223K ﹤0.01%
6,750
LHCG
1379
DELISTED
LHC Group LLC
LHCG
$223K ﹤0.01%
1,115
SGOL icon
1380
abrdn Physical Gold Shares ETF
SGOL
$7.01B
$222K ﹤0.01%
13,080
CRNT icon
1381
Ceragon Networks
CRNT
$197M
$221K ﹤0.01%
58,500
+2,000
+4% +$7.08K
FPXI icon
1382
First Trust Exchange-Traded Fund II First Trust International Equity Opportunities ETF
FPXI
$273M
$221K ﹤0.01%
3,235
-6,602
-67% -$443K
CSWC icon
1383
Capital Southwest
CSWC
$1.47B
$220K ﹤0.01%
+9,459
New +$235K
BTX
1384
BlackRock Technology and Private Equity Term Trust
BTX
$922M
$220K ﹤0.01%
+10,835
New +$226K
EMLP icon
1385
First Trust North American Energy Infrastructure Fund
EMLP
$4.09B
$219K ﹤0.01%
8,951
-661
-7% -$16K
NAGE
1386
Niagen Bioscience
NAGE
$264M
$219K ﹤0.01%
22,210
+2,600
+13% +$22.7K
TOL icon
1387
Toll Brothers
TOL
$14B
$218K ﹤0.01%
+3,773
New +$230K
XSMO icon
1388
Invesco S&P SmallCap Momentum ETF
XSMO
$3.01B
$218K ﹤0.01%
3,987
XRX icon
1389
Xerox
XRX
$456M
$217K ﹤0.01%
9,218
-58
-0.6% -$1.4K
BANX
1390
ArrowMark Financial
BANX
$196M
$216K ﹤0.01%
+9,792
New +$205K
VOE icon
1391
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.8B
$215K ﹤0.01%
+1,529
New +$216K
PLUG icon
1392
Plug Power
PLUG
$2.92B
$214K ﹤0.01%
6,269
-1,041
-14% -$30.2K
DEM icon
1393
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.9B
$213K ﹤0.01%
+4,667
New +$214K
EMD
1394
Western Asset Emerging Markets Debt Fund
EMD
$611M
$213K ﹤0.01%
15,199
-1,409
-8% -$19.4K
STM icon
1395
STMicroelectronics
STM
$47.3B
$213K ﹤0.01%
5,855
-22
-0.4% -$823
HIG icon
1396
Hartford Financial Services
HIG
$39.2B
$212K ﹤0.01%
3,424
LBRDA icon
1397
Liberty Broadband Class A
LBRDA
$4.78B
$212K ﹤0.01%
+1,261
New +$197K
AUB icon
1398
Atlantic Union Bankshares
AUB
$6B
$211K ﹤0.01%
5,824
BFK
1399
DELISTED
BlackRock Municipal Income Trust
BFK
$211K ﹤0.01%
13,687
+173
+1% +$2.61K
IHDG icon
1400
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.23B
$211K ﹤0.01%
4,782
-747
-14% -$32.3K

Similar funds

Oppenheimer & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Oppenheimer & Co held 1,590 positions worth $5.58B, up 11% from $5.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co deployed $189M of net new capital in Q2 2021, opening 158 new positions and adding to 732 existing holdings. Its largest new stake was Equity Commonwealth: 133,173 shares worth $3.49M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg Convertible Securities ETF, an estimated $8.63M trimmed.

  • Oppenheimer & Co's largest Q2 2021 buy was Equity Commonwealth: 133,173 shares worth $3.49M.
  • Oppenheimer & Co added most to Amazon in Q2 2021, an estimated $10.8M increase.
  • Oppenheimer & Co's biggest Q2 2021 reduction was State Street SPDR Bloomberg Convertible Securities ETF, cutting an estimated $8.63M.
  • Oppenheimer & Co fully exited Armstrong World Industries in Q2 2021, selling an estimated $7.38M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5.58B portfolio in Q2 2021.
  • Oppenheimer & Co opened 158 new positions and closed 88 in Q2 2021.
  • Oppenheimer & Co's portfolio value rose 11% quarter-over-quarter to $5.58B.

Based on Oppenheimer & Co's 13F filing for Q2 2021, filed 3 Aug 2021.